as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
and probiotics' role on oral health.
It has also proved beneficial for the treatments of many gastrointestinal infections as in oral bacteriotherapy
because of its alkaliphilic property , it is also used as probiotics .
See, e.g., Alexander Khoruts et al., Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy
for Recurrent Clostridium difficile-Associated Diarrhea, 44 J.
Fecal microbiota transplantation (FMT) is the process of fecal bacteriotherapy
, fecal transfusion and gaita transplantation by other names in the terminology, the placement of gaita from a healthy donor into the gastrointestinal tract of the recipient.
In this regard, "bacteriotherapy
," such as the administration of "good" bacteria, could prevent the onset of respiratory infections and consequently avoid antibiotic resistance (4).
In Vitro and In Vivo assessment of intraintestinal bacteriotherapy
in chronic kidney disease.
We searched for articles published in PubMed and Web of Science with the following MeSH terms for fecal microbiota transplant: "fecal microbiota transplantation," "faecal microbiota transplantation," "fecal transfusion," "fecal therapy," "microbiota implant," "flora implantation," "bacteriotherapy
," and "FMT." Then, the results were combined using "AND" with studies identified by alternatives for UC: "ulcerative colitis," "UC," "colitis," "inflammatory bowel diseases," and "IBD." We enrolled all relevant articles to May 5, 2017, by reviewing the titles and abstracts about FMT in IBD or UC.
Speziale, "Efficacious outcome employing fecal bacteriotherapy
in severe Crohn's colitis complicated by refractory Clostridium difficile infection," Infection, vol.
is a clinical procedure, in which a liquid suspension of stool from a human donor (a family member or a disease-free screened donor) is inoculated into gut's patients to restore gut microbiota in refractory cases of Clostridium difficile colorectal infection after antibiotic therapy [90, 91].
Ranganathan et al., "In vitro and in vivo assessment of intraintestinal bacteriotherapy
in chronic kidney disease," ASAIO Journal, vol.
The first mention of topical probiotics as a therapeutic treatment for skin conditions appeared in the medical literature in 1912, and was termed "topical bacteriotherapy
." It was not until 1999 that researchers were able to hone-in on exactly how probiotic application to the skin might improve dermatological health.